Trends in first-time prescribing First-time prescribing rates (first-time GLP-1 RA prescriptions per total prescriptions) in September 2025 are slightly decreased compared to June 2025 (-12.5%)
Improved health markers: In addition to weight loss, patients can anticipate improved health markers and lab results, such as balanced blood sugar, cholesterol, and blood pressure levels
Suicidal ideation and behavior have been observed with other weightmanagement agents, and Wegovy carries a classconsistent warning
Henceforth, meticulous regulation of iron metabolism is imperative within the human body
Wegovy, a brand name of semaglutide, has been associated with these side effects: Nausea and vomiting Diarrhea or constipation Stomach pain or indigestion Decreased appetite leading to weight loss Fatigue and dizziness Increased heart rate Insomnia (difficulty sleeping) In rare cases, patients may also experience: Tremors and feelings of anxiety or nervousness